Life Sciences & Pharma Presentations European Disease Progression Monitor: Edition 3 April 14, 2020 Weekly focus – A consistent pattern of lockdown exit strategies is emerging, with an initial focus on reopening childcare and small retail businesses.
Life Sciences & Pharma Executive Insights CAR-T: Unlocking Barriers to Adoption in Europe June 23, 2020 L.E.K. Consulting reviews progress to date, outlines barriers to uptake and identifies potential catalysts for accelerating European CAR-T adoption.
Strategy Presentations Global Situation Report Insights: Edition 2 June 9, 2020 The L.E.K. Global Situation Report is a uniquely rich, current, and customisable collection of indicators that provide a powerful recovery planning aide.
Life Sciences & Pharma Presentations COVID-19 Therapeutic Research and Development Landscape June 3, 2020 The following materials provide a snapshot of the unprecedented scope and speed of biopharma’s therapeutics research and development (R&D) response to…
Life Sciences & Pharma Executive Insights European Drug Pricing and Market Access in a COVID-19 World October 14, 2020 On 3 June 2020, Médecins Sans Frontières (MSF) issued an appeal urging world leaders to ensure that pharmaceutical companies sell any COVID-19 vaccines at…
Life Sciences & Pharma Presentations European Disease Progression Monitor: Edition 6 May 11, 2020 The COVID-19 Disease Progression Monitor delivers evidence on the effects of the disease on services, systems and therapies
